EmpiRx Health saw a significant increase in pharmacy claims for behavioral health therapies but found managing these treatments in a value-based approach can mitigate the costs.
The pharmacy benefit manager saw claims for behavioral health treatments grow 9.4% between 2020 and 2021, according to a new report released Thursday. Utilization of antidepressant medications grew by 12% year over year, and use of treatments for attention-deficit/hyperactivity disorder (ADHD) increased by 20.2%.
However, per claim spend for antidepressants declined by 1.8% between 2020 and 2021, and per claim spend for ADHD drugs decreased by 9.1%, the PBM said.
